Visser, Margaretha M. http://orcid.org/0000-0003-0216-4028
Gillard, Pieter
Article History
First Online: 15 February 2024
Competing interests
: UZ Leuven received non-financial support for travel from Novo Nordisk, and Boehringer-Ingelheim for M.M.V. M.M.V. serves or has served on the speakers bureau for Dexcom — financial compensation for these activities has been received by KU Leuven. P.G. serves or has served on the advisory panel for Novo Nordisk, Sanofi-Aventis, Boehringer-Ingelheim, Janssen Pharmaceuticals, Roche, Medtronic, Abbott and Bayer. Financial compensation for these activities has been received by KU Leuven. P.G. serves or has served on the speakers bureau for Merck Sharp and Dohme, Boehringer-Ingelheim, Bayer, Medtronic, Insulet, Novo Nordisk, Abbott, Roche, VitalAire and Dexcom. Financial compensation for these activities has been received by KU Leuven. KU Leuven received for P.G. non-financial support for travel from Sanofi-Aventis, A. Menarini Diagnostics, Novo Nordisk, Medtronic, and Roche. All disclosures were unrelated to the present work.